NewSquare Capital’s Amedisys AMED Stock Holding History

NewSquare Capital’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,855	Closed	-$643K	–	348
2019 Q4	$643K	Buy	+3,855	New	+$573K	0.11%	97

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NewSquare Capital's AMED Position: Q1 2020 in Review

NewSquare Capital sold out of Amedisys (AMED) in Q1 2020, closing a stake of 3,855 shares — an estimated $643K sold.

NewSquare Capital first reported a position in AMED in Q4 2019 and held it in 1 quarter. The position peaked at $643K in Q4 2019. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

NewSquare Capital reported no remaining Amedisys position as of Q1 2020 after selling out during the quarter.
NewSquare Capital sold 3,855 Amedisys shares in Q1 2020, an estimated $643K.
NewSquare Capital first reported a position in Amedisys in Q4 2019 and held it in 1 quarter.
NewSquare Capital's Amedisys position peaked at $643K in Q4 2019.
332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on NewSquare Capital's 13F filing for Q1 2020, filed 8 May 2020.